Skip to main content
. 2017 Nov 15;34(2):353–364. doi: 10.3904/kjim.2016.285

Table 4.

Non-fasting TG levels according to presence or absence of IHD/CVA history

Fasting duration, hr Unweighted no. IHD/CVA (–), mg/dL, Mean ± SE IHD/CVA (+), mg/dL, Mean ± SE p valuea p valueb p valuec p valued p valuee
Male
 Entire population 0–3 143 157.0 ± 10.7 164.6 ± 26.9 0.740 0.622 0.655 0.589 0.633
4–7 145 181.9 ± 11.6 194.5 ± 27.8 0.237 0.139 0.130 0.167 0.149
8–11 2,035 152.9 ± 2.7 142.9 ± 9.0 0.599 0.107 0.034 0.066 0.116
≥ 12 7,832 146.8 ± 1.4 144.0 ± 5.8 0.429 0.122 0.077 0.149 0.087
 No diabetes 0–3 112 154.7 ± 12.6 141.2 ± 28.8 0.804 0.654 0.652 0.289 0.400
4–7 131 177.3 ± 11.6 215.1 ± 23.8 0.003 < 0.001 < 0.001 < 0.001 < 0.001
8–11 1,764 149.0 ± 2.8 147.7 ± 11.6 0.887 0.566 0.386 0.341 0.306
≥ 12 6,702 142.3 ± 1.4 138.7 ± 5.1 0.795 0.342 0.291 0.541 0.414
Female
 Entire population 0–3 258 132.9 ± 6.5 161.3 ± 13.5 < 0.001 0.449 0.657 0.703 0.576
4–7 130 124.1 ± 9.2 152.2 ± 27.6 0.305 0.755 0.774 0.901 0.429
8–11 2,759 114.8 ± 1.9 143.8 ± 11.2 0.005 0.735 0.549 0.228 0.161
≥ 12 14,788 117.1 ± 0.8 147.7 ± 4.1 < 0.001 0.303 0.309 0.365 0.378
 No diabetes 0–3 225 128.9 ± 7.0 165.6 ± 17.0 0.001 0.478 0.628 0.705 0.538
4–7 113 117.1 ± 9.6 109.3 ± 40.7 0.871 0.604 0.600 0.900 0.394
8–11 2,478 109.4 ± 1.9 137.2 ± 13.4 0.039 0.984 0.803 0.413 0.348
≥ 12 13,210 112.3 ± 0.8 143.0 ± 4.7 < 0.001 0.188 0.159 0.211 0.175

TG, triglyceride; IHD, ischemic heart disease; CVA, cerebrovascular accident.

a

Compared TG level according to presence or absence of IHD/CVA without adjustment.

b

Compared TG level according to presence or absence of IHD/CVA with adjustment for age and body mass index.

c

Compared TG level according to presence or absence of IHD/CVA with adjustment for age, body mass index, and lipid medication.

d

Compared TG level according to presence or absence of IHD/CVA with adjustment for age, body mass index, lipid medication, exercise, and daily carbohydrate and fat intake.

e

Compared TG level according to presence or absence of IHD/CVA with adjustment for age, body mass index, lipid medication, exercise, daily carbohydrate and fat intake, hypertension, and low density lipoprotein cholesterol level.